| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
| A-Thalassemia | 0 | low | 1 | 0 |
| Alpha Thalassemia | 0 | low | 1 | 0 |
| alpha-Thalassemia | 0 | low | 1 | 0 |
| Anemia | 0 | medium | 9 | 3 |
| Anemia With Multinucleated Erythroblasts | 0 | low | 1 | 0 |
| Anemia, Congenital Dyserythropoietic | 0 | low | 1 | 0 |
| Anemia, Congenital Dyserythropoietic, Type II | 0 | low | 1 | 0 |
| Anemia, Congenital Hypoplastic, Of Blackfan And Diamond | 0 | low | 2 | 0 |
| Anemia, Cooley's | 0 | medium | 6 | 1 |
| Anemia, Diamond-Blackfan | 0 | low | 2 | 0 |
| Anemia, Diamond-Blackfan Type | 0 | low | 2 | 0 |
| Anemia, Dyserythropoietic Congenital, Type I | 0 | low | 1 | 0 |
| Anemia, Dyserythropoietic Congenital, Type II | 0 | low | 1 | 0 |
| Anemia, Dyserythropoietic Congenital, Type III | 0 | low | 1 | 0 |
| Anemia, Dyserythropoietic, Congenital | 0 | low | 1 | 0 |
| Anemia, Dyserythropoietic, Congenital Type 1 | 0 | low | 1 | 0 |
| Anemia, Dyserythropoietic, Congenital Type 2 | 0 | low | 1 | 0 |
| Anemia, Dyserythropoietic, Congenital, Type I | 0 | low | 1 | 0 |
| Anemia, Dyserythropoietic, Congenital, Type II | 0 | low | 1 | 0 |
| Anemia, Dyserythropoietic, Congenital, Type III | 0 | low | 1 | 0 |
| Anemia, Erythroblastic | 0 | medium | 6 | 1 |
| Anemia, Mediterranean | 0 | medium | 6 | 1 |
| Anoxemia | 0 | low | 1 | 0 |
| Anoxia | 0 | low | 1 | 0 |
| beta Thalassemia | 0 | medium | 6 | 1 |
| beta-Thalassemia | 0 | medium | 6 | 1 |
| Blackfan Diamond Anemia | 0 | low | 2 | 0 |
| Blackfan-Diamond Disease | 0 | low | 2 | 0 |
| Blackfan-Diamond Syndrome | 0 | low | 2 | 0 |
| Bone Cancer | 0 | low | 1 | 0 |
| Bone Diseases | 0 | low | 1 | 0 |
| Bone Diseases, Metabolic | 0 | low | 1 | 0 |
| Bone Loss, Osteoclastic | 0 | medium | 1 | 1 |
| Bone Neoplasms | 0 | low | 1 | 0 |
| Bone Resorption | 0 | medium | 1 | 1 |
| Breast Cancer | 0 | medium | 2 | 1 |
| Breast Carcinoma | 0 | medium | 2 | 1 |
| Breast Neoplasms | 0 | medium | 2 | 1 |
| Breast Tumors | 0 | medium | 2 | 1 |
| Cancer of Bone | 0 | low | 1 | 0 |
| Cancer of Breast | 0 | medium | 2 | 1 |
| Cancer of the Bone | 0 | low | 1 | 0 |
| Cancer of the Breast | 0 | medium | 2 | 1 |
| Chronic Congenital Agenerative Anemia | 0 | low | 2 | 0 |
| Chronic Kidney Diseases | 0 | low | 2 | 0 |
| Chronic Kidney Insufficiency | 0 | low | 2 | 0 |
| Chronic Renal Diseases | 0 | low | 2 | 0 |
| Chronic Renal Insufficiency | 0 | low | 2 | 0 |
| Congenital Dyserythropoietic Anemia | 0 | low | 1 | 0 |
| Congenital Dyserythropoietic Anemia Type 1 | 0 | low | 1 | 0 |
| Congenital Dyserythropoietic Anemia Type II | 0 | low | 1 | 0 |
| Congenital Dyserythropoietic Anemia, Type I | 0 | low | 1 | 0 |
| Congenital Dyserythropoietic Anemia, Type III | 0 | low | 1 | 0 |
| Congenital Erythroid Hypoplastic Anemia | 0 | low | 2 | 0 |
| Congenital Hypoplastic Anemia of Blackfan and Diamond | 0 | low | 2 | 0 |
| Congenital Pure Red Cell Anemia | 0 | low | 2 | 0 |
| Congenital Pure Red Cell Aplasia | 0 | low | 2 | 0 |
| Cryptogenic Fibrosing Alveolitis | 0 | low | 1 | 0 |
| Deficiency, Oxygen | 0 | low | 1 | 0 |
| Diamond-Blackfan Anemia | 0 | low | 2 | 0 |
| Disease Exacerbation | 0 | low | 2 | 0 |
| Disease Models, Animal | 0 | low | 6 | 0 |
| Disease Progression | 0 | low | 2 | 0 |
| Dyserythropoietic Anemia, Congenital | 0 | low | 1 | 0 |
| Dyserythropoietic Anemia, Congenital Type 1 | 0 | low | 1 | 0 |
| Dyserythropoietic Anemia, Congenital Type 2 | 0 | low | 1 | 0 |
| Dyserythropoietic Anemia, Congenital, Type I | 0 | low | 1 | 0 |
| Dyserythropoietic Anemia, Congenital, Type II | 0 | low | 1 | 0 |
| Dyserythropoietic Anemia, Congenital, Type III | 0 | low | 1 | 0 |
| Dyserythropoietic Anemia, HEMPAS Type | 0 | low | 1 | 0 |
| Dysmyelopoietic Syndromes | 0 | medium | 3 | 1 |
| Erythroblastic Anemia | 0 | medium | 6 | 1 |
| Erythrogenesis Imperfecta | 0 | low | 2 | 0 |
| Familial Idiopathic Pulmonary Fibrosis | 0 | low | 1 | 0 |
| Familial Primary Pulmonary Hypertension | 0 | medium | 5 | 1 |
| Fibrocystic Pulmonary Dysplasia | 0 | low | 1 | 0 |
| Fibrosing Alveolitis, Cryptogenic | 0 | low | 1 | 0 |
| Hematopoetic Myelodysplasia | 0 | medium | 3 | 1 |
| Hemoglobin F Disease | 0 | medium | 6 | 1 |
| Hemoglobin H Disease | 0 | low | 1 | 0 |
| Hemoglobinopathies | 0 | low | 1 | 0 |
| Hemoglobinuria | 0 | low | 1 | 0 |
| HEMPAS | 0 | low | 1 | 0 |
| HEMPAS Anemia | 0 | low | 1 | 0 |
| Hereditary Erythroblast Multinuclearity with Positive Acidified Serum | 0 | low | 1 | 0 |
| Hereditary Erythroblastic Multinuclearity with Positive Acidified-Serum Test | 0 | low | 1 | 0 |
| Heritable Pulmonary Arterial Hypertension | 0 | medium | 5 | 1 |
| Human Mammary Carcinoma | 0 | medium | 2 | 1 |
| Hypercoagulability | 0 | low | 1 | 0 |
| Hypertension, Pulmonary | 0 | medium | 5 | 2 |
| Hypoplastic Congenital Anemia | 0 | low | 2 | 0 |
| Hypoxemia | 0 | low | 1 | 0 |
| Hypoxia | 0 | low | 1 | 0 |
| Idiopathic Fibrosing Alveolitis, Chronic Form | 0 | low | 1 | 0 |
| Idiopathic Pulmonary Arterial Hypertension | 0 | medium | 5 | 1 |
| Idiopathic Pulmonary Fibrosis | 0 | low | 1 | 0 |
| Idiopathic Pulmonary Fibrosis, Familial | 0 | low | 1 | 0 |
| Idiopathic Pulmonary Hypertension | 0 | medium | 5 | 1 |
| Inflammation | 0 | low | 1 | 0 |
| Inherited Erythroblastopenia | 0 | low | 2 | 0 |
| Innate Inflammatory Response | 0 | low | 1 | 0 |
| Interstitial Pneumonitis, Usual | 0 | low | 1 | 0 |
| Iron Overload | 0 | low | 2 | 0 |
| Kahler Disease | 0 | medium | 2 | 1 |
| Kidney Insufficiency, Chronic | 0 | low | 2 | 0 |
| Low Bone Density | 0 | low | 1 | 0 |
| Low Bone Mineral Density | 0 | low | 1 | 0 |
| Malignant Neoplasm of Breast | 0 | medium | 2 | 1 |
| Malignant Tumor of Breast | 0 | medium | 2 | 1 |
| Mammary Cancer | 0 | medium | 2 | 1 |
| Mammary Carcinoma, Human | 0 | medium | 2 | 1 |
| Mammary Neoplasm, Human | 0 | medium | 2 | 1 |
| Mammary Neoplasms, Human | 0 | medium | 2 | 1 |
| Mediterranean Anemia | 0 | medium | 6 | 1 |
| Metabolic Bone Diseases | 0 | low | 1 | 0 |
| Microcytemia, beta Type | 0 | medium | 6 | 1 |
| Multiple Myeloma | 0 | medium | 2 | 1 |
| Myelodysplastic Syndromes | 0 | medium | 3 | 1 |
| Myeloma-Multiple | 0 | medium | 2 | 1 |
| Myeloma, Multiple | 0 | medium | 2 | 1 |
| Myeloma, Plasma-Cell | 0 | medium | 2 | 1 |
| Myelomatosis | 0 | medium | 2 | 1 |
| Neoplasms, Bone | 0 | low | 1 | 0 |
| Neoplasms, Breast | 0 | medium | 2 | 1 |
| Osteoclastic Bone Loss | 0 | medium | 1 | 1 |
| Osteolysis | 0 | medium | 1 | 1 |
| Osteopenia | 0 | low | 1 | 0 |
| Oxygen Deficiency | 0 | low | 1 | 0 |
| Plasma Cell Myeloma | 0 | medium | 2 | 1 |
| Pph1 With Hht | 0 | medium | 5 | 1 |
| Primary Pulmonary Hypertension | 0 | medium | 5 | 1 |
| Pulmonary Arterial Hypertension | 0 | medium | 12 | 3 |
| Pulmonary Fibrosis, Idiopathic | 0 | low | 1 | 0 |
| Pulmonary Hypertension | 0 | medium | 5 | 2 |
| Pulmonary Hypertension, Primary, 1 | 0 | medium | 5 | 1 |
| Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia | 0 | medium | 5 | 1 |
| Pulmonary Hypertension, Primary, Dexfenfluramine-Associated | 0 | medium | 5 | 1 |
| Pulmonary Hypertension, Primary, Fenfluramine-Associated | 0 | medium | 5 | 1 |
| Pure Hereditary Red Cell Aplasia | 0 | low | 2 | 0 |
| Red Cell Aplasia, Pure, Hereditary | 0 | low | 2 | 0 |
| Renal Insufficiency, Chronic | 0 | low | 2 | 0 |
| Thalassemia | 0 | low | 1 | 0 |
| Thalassemia Intermedia | 0 | medium | 6 | 1 |
| Thalassemia Major | 0 | medium | 6 | 1 |
| Thalassemia Major (beta-Thalassemia Major) | 0 | medium | 6 | 1 |
| Thalassemia Minor | 0 | medium | 6 | 1 |
| Thalassemia Minor (beta-Thalassemia Minor) | 0 | medium | 6 | 1 |
| Thalassemia-alpha | 0 | low | 1 | 0 |
| Thalassemia, beta Type | 0 | medium | 6 | 1 |
| Thalassemias | 0 | low | 1 | 0 |
| Thrombocytopenia | 0 | medium | 1 | 1 |
| Thrombopenia | 0 | medium | 1 | 1 |
| Thrombophilia | 0 | low | 1 | 0 |
| Tumors, Breast | 0 | medium | 2 | 1 |
| Type I Congenital Dyserythropoietic Anemia | 0 | low | 1 | 0 |
| Usual Interstitial Pneumonia | 0 | low | 1 | 0 |